JESSICA BROWN: Open Payments
NPI 1356987457 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 96 payments from 13 companies in 2025. Trend: 2023 $1,251 · 2024 $1,242 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $746 |
| Janssen Biotech, Inc. | 13 | $252 |
| Ardelyx, Inc. | 10 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $227 |
| PFIZER INC. | 6 | $109 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $45 |
| EVOKE PHARMA, INC. | 2 | $44 |
| Madrigal Pharmaceuticals | 1 | $43 |
| GENZYME CORPORATION | 1 | $35 |
Products named: RINVOQ, TREMFYA, IBSRELA, LINZESS, ENTYVIO, SKYRIZI, CREON, IQIRVO.
Industry payments across GA — which companies pay providers there.
